Ligand Pharmaceuticals Incorporated (LGND) Fell -7.36% or -12.6 To Price $158.59 On Friday


Ligand Pharmaceuticals Incorporated (LGND) fell -7.36% or -12.6 to $158.59. It is close to 813007 shares traded, which is 91.06% compare to the average total volume 892787. The market cap of LGND is $3.35 billion. The year to date change is 16.13%. The 52 week price range is from $126.5 to $278.62. Price of LGND have changed 3.30% during last week. It have changed -30.72% over last month, -28.16% over last 3 months, 8.84% over last 6 months and 16.42% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for LGND is 225.06. It is 41.91% above current price. The 200-day Moving Averages for LGND is 197.64. It is 24.62% above current price. The 52-week High is 278.62. It is 75.69% from the current price. The 52-week Low is 126.5. It is -20.23% from current price.

There are some statistics of LGND. It is has market cap $3.35 billion. The share outstanding is 21.10 million. The average volume is 892787. The revenue is 33.38M. The gross profit is 30.99M. The percent of top 15 Institution holding is 73.80%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of LGND is 23.65%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of LGND is 9.54%.


Tags:

Share this post